China Medicine Corporation (CHME)
OTCMKTS · Delayed Price · Currency is USD
0.0006
+0.0001 (20.00%)
At close: Aug 13, 2025
China Medicine Revenue
China Medicine had revenue of $17.55M in the quarter ending September 30, 2010, a decrease of -8.38%. This brings the company's revenue in the last twelve months to $65.76M, down -4.34% year-over-year. In the year 2009, China Medicine had annual revenue of $64.75M with 20.70% growth.
Revenue (ttm)
65.76M
Revenue Growth
-4.34%
P/S Ratio
0.00
Revenue / Employee
234.00K
Employees
281
Market Cap
14.35K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2009 | 64.75M | 11.10M | 20.70% |
| Dec 31, 2008 | 53.65M | 11.54M | 27.41% |
| Dec 31, 2007 | 42.11M | 18.11M | 75.50% |
| Dec 31, 2006 | 23.99M | 9.07M | 60.74% |
| Dec 31, 2005 | 14.93M | 4.53M | 43.51% |
| Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 105.45M |
| Tian'an Technology Group | 2.12M |
| Glass House Brands | 221.55M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Longduoduo Company | 4.99M |